samplename	Sample	status	time	histology	Stage	age	gender	adjuvant_treatment	recurrence	days_to_recurrence	FileName	ScanDate	Cluster	GSE	T	N	M	tobacco_history	recurrence_time	post_surgical_treatment	Cause_of_death	DSS_time	DSS
1	Patient 12	GSM1019140	1	5.4	adeno	StageI-II	>= 65	Male	1	3	5.13333333333333	GSM1019140_PA025_human_12B_070912.CEL.gz	2009-07-12	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
2	Patient 35	GSM1019149	1	19.8333333333333	adeno	StageI-II	>= 65	Female	1	2	NA	GSM1019149_PA025_human_35A_070912.CEL.gz	2009-07-12	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
3	Patient 37	GSM1019150	1	61.3	adeno	StageI-II	>= 65	Female	2	2	NA	GSM1019150_PA025_human_37A_070228.CEL.gz	2002-07-28	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
4	Patient 162	GSM1019162	1	11.8333333333333	adeno	StageI-II	>= 65	Male	3	1	11.9666666666667	GSM1019162_PA025_human_162A_070509.CEL.gz	2005-07-09	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
5	Patient 193	GSM1019171	1	108.666666666667	adeno	StageI-II	< 65	Female	1	1	84.3666666666667	GSM1019171_PA025_193B_081106_HG-U133_Plus_2_.CEL.gz	2008-11-06	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
6	Patient 197	GSM1019174	1	17.1333333333333	adeno	StageI-II	>= 65	Male	3	3	16.7666666666667	GSM1019174_PA025_human_197B_070509.CEL.gz	2005-07-09	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
7	Patient 213	GSM1019181	1	107.366666666667	adeno	StageI-II	< 65	Female	1	3	85.9666666666667	GSM1019181_PA025_213A_081029_HG-U133_Plus_2_.CEL.gz	2008-10-29	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
8	Patient 215	GSM1019183	1	19.7	adeno	StageI-II	< 65	Female	1	3	6.33333333333333	GSM1019183_PA025_215A_090128_HG-U133_Plus_2_.CEL.gz	2009-01-28	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
9	Patient 223	GSM1019185	1	123.966666666667	adeno	StageI-II	< 65	Male	3	3	96.8333333333333	GSM1019185_PA025_223A_081028_HG-U133_Plus_2_.CEL.gz	2008-10-28	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
10	Patient 235	GSM1019190	0	120.7	adeno	StageI-II	>= 65	Female	1	1	57.6	GSM1019190_PA025_human_235A_070912.CEL.gz	2009-07-12	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
11	Patient 282	GSM1019203	1	2.63333333333333	adeno	StageI-II	>= 65	Female	2	2	NA	GSM1019203_PA025_282A_081029_HG-U133_Plus_2_.CEL.gz	2008-10-29	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
12	Patient 299	GSM1019211	1	10.7666666666667	adeno	StageIII-IV	< 65	Female	3	3	10.2	GSM1019211_PA025_human_299B_070912.CEL.gz	2009-07-12	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
13	Patient 301	GSM1019213	0	149.633333333333	adeno	StageI-II	< 65	Male	1	3	125.333333333333	GSM1019213_PA025_301A_081029_HG-U133_Plus_2_.CEL.gz	2008-10-29	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
14	Patient 302	GSM1019214	0	149.533333333333	adeno	StageI-II	< 65	Female	1	1	69.4666666666667	GSM1019214_PA025_302A_081106_HG-U133_Plus_2_.CEL.gz	2008-11-06	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
15	Patient 317	GSM1019220	1	17.7666666666667	adeno	StageI-II	< 65	Female	1	3	4.6	GSM1019220_PA025_human_317A_070926.CEL.gz	2009-07-26	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
16	Patient 359	GSM1019230	1	79.9	adeno	StageIII-IV	>= 65	Female	3	1	75.5666666666667	GSM1019230_PA025_human_359A_070907.CEL.gz	2009-07-07	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
17	Patient 16	GSM1019242	0	107.566666666667	adeno	StageI-II	>= 65	Female	1	1	69.5333333333333	GSM1019242_PA117_16A_101118_HG-U133_Plus_2_.CEL.gz	2010-11-18	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
18	Patient 41	GSM1019249	0	95.5333333333333	adeno	StageI-II	>= 65	Female	2	2	NA	GSM1019249_PA117_41A_101123_HG-U133_Plus_2_.CEL.gz	2010-11-23	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
19	Patient 58	GSM1019254	0	92.0333333333333	adeno	StageI-II	< 65	Female	2	2	NA	GSM1019254_PA117_58A_101123_HG-U133_Plus_2_.CEL.gz	2010-11-23	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
20	Patient 80	GSM1019265	0	77.2	adeno	StageI-II	< 65	Female	2	2	NA	GSM1019265_PA117_80A_101203_HG-U133_Plus_2_.CEL.gz	2010-12-03	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
21	Patient 110	GSM1019273	1	48.7666666666667	adeno	StageI-II	< 65	Female	2	2	NA	GSM1019273_PA117_110A_101126_HG-U133_Plus_2_.CEL.gz	2010-11-26	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
22	Patient 114	GSM1019275	1	10.6333333333333	adeno	StageI-II	>= 65	Female	1	3	5.4	GSM1019275_PA117_114A_101215_HG-U133_Plus_2_.CEL.gz	2010-12-15	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
23	Patient 147	GSM1019283	0	64.2666666666667	adeno	StageI-II	>= 65	Female	2	2	NA	GSM1019283_PA117_147A_101203_HG-U133_Plus_2_.CEL.gz	2010-12-03	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
24	Patient 150	GSM1019285	0	60.8666666666667	adeno	StageI-II	< 65	Female	2	2	NA	GSM1019285_PA117_150A_101130_HG-U133_Plus_2_.CEL.gz	2010-11-30	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
25	Patient 154	GSM1019286	1	25.2	adeno	StageI-II	>= 65	Male	2	2	NA	GSM1019286_PA117_154A_101130_HG-U133_Plus_2_.CEL.gz	2010-11-30	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
26	Patient 160	GSM1019288	0	61.9666666666667	adeno	StageI-II	< 65	Female	2	2	NA	GSM1019288_PA117_160A_101130_HG-U133_Plus_2_2.CEL.gz	2010-11-30	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
27	Patient 163	GSM1019289	1	33.7	adeno	StageI-II	>= 65	Male	2	2	NA	GSM1019289_PA117_163A_101130_HG-U133_Plus_2_.CEL.gz	2010-11-30	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
28	Patient 180	GSM1019295	0	158.666666666667	adeno	StageI-II	>= 65	Female	1	1	168.4	GSM1019295_PA117_180A_101130_HG-U133_Plus_2_.CEL.gz	2010-11-30	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
29	Patient 186	GSM1019298	1	33.5666666666667	adeno	StageI-II	< 65	Female	2	2	NA	GSM1019298_PA117_186B_101130_HG-U133_Plus_2_.CEL.gz	2010-11-30	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
30	Patient 209	GSM1019302	0	135.6	adeno	StageI-II	< 65	Female	1	1	78.9666666666667	GSM1019302_PA117_209A_101202_HG-U133_Plus_2_.CEL.gz	2010-12-02	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
31	Patient 241	GSM1019308	1	40.7	adeno	StageI-II	>= 65	Male	2	2	NA	GSM1019308_PA117_241B_101203_HG-U133_Plus_2_.CEL.gz	2010-12-03	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
32	Patient 244	GSM1019309	1	32.6333333333333	adeno	StageI-II	>= 65	Female	2	2	NA	GSM1019309_PA117_244A_101203_HG-U133_Plus_2_.CEL.gz	2010-12-03	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
33	Patient 263	GSM1019312	1	72.2333333333333	adeno	StageIII-IV	>= 65	Male	2	2	NA	GSM1019312_PA117_263A_101210_HG-U133_Plus_2_.CEL.gz	2010-12-10	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
34	Patient 327	GSM1019324	1	93.6666666666667	adeno	StageI-II	>= 65	Male	1	1	17.7	GSM1019324_PA117_327A_101210_HG-U133_Plus_2_.CEL.gz	2010-12-10	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
35	Patient 348	GSM1019328	1	37.1	adeno	StageI-II	< 65	Male	2	2	NA	GSM1019328_PA117_348A_101208_HG-U133_Plus_2_.CEL.gz	2010-12-08	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
36	Patient 360	GSM1019332	1	33.8333333333333	adeno	StageI-II	< 65	Female	2	2	NA	GSM1019332_PA117_360A_101208_HG-U133_Plus_2_.CEL.gz	2010-12-08	Cluster1	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
37	Patient 169	GSM1019164	1	9.53333333333333	adeno	StageIII-IV	< 65	Female	1	3	7.96666666666667	GSM1019164_PA025_human_169D_070228.CEL.gz	2002-07-28	Cluster2	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
38	Patient 212	GSM1019180	1	11.4333333333333	adeno	StageI-II	>= 65	Male	1	3	3.86666666666667	GSM1019180_PA025_212A_081029_HG-U133_Plus_2_.CEL.gz	2008-10-29	Cluster2	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
39	Patient 288	GSM1019205	0	156.766666666667	adeno	StageI-II	< 65	Male	3	1	165.933333333333	GSM1019205_PA025_human_288A_070914.CEL.gz	2009-07-14	Cluster2	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
40	Patient 311	GSM1019218	1	8.73333333333333	adeno	StageI-II	>= 65	Male	1	3	5.96666666666667	GSM1019218_PA025_311C_081106_HG-U133_Plus_2_.CEL.gz	2008-11-06	Cluster2	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
41	Patient 341	GSM1019225	1	5.9	adeno	StageI-II	< 65	Female	1	1	0.233333333333333	GSM1019225_PA025_341A_081106_HG-U133_Plus_2_.CEL.gz	2008-11-06	Cluster2	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
42	Patient 74	GSM1019260	0	78.3333333333333	adeno	StageI-II	< 65	Male	2	2	NA	GSM1019260_PA117_74A_101215_HG-U133_Plus_2_.CEL.gz	2010-12-15	Cluster2	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
43	Patient 257	GSM1019311	1	56.2333333333333	adeno	StageI-II	>= 65	Female	2	2	NA	GSM1019311_PA117_257A_101208_HG-U133_Plus_2_.CEL.gz	2010-12-08	Cluster2	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
44	Patient 276	GSM1019314	0	163.233333333333	adeno	StageI-II	>= 65	Male	1	1	28.9666666666667	GSM1019314_PA117_276B_101208_HG-U133_Plus_2_.CEL.gz	2010-12-08	Cluster2	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
45	Patient 318	GSM1019321	0	173.566666666667	adeno	StageI-II	< 65	Male	1	1	180.766666666667	GSM1019321_PA117_318B_101208_HG-U133_Plus_2_.CEL.gz	2010-12-08	Cluster2	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
46	Patient 11	GSM1019139	0	106.2	adeno	StageI-II	>= 65	Female	1	3	107.433333333333	GSM1019139_PA025_human_11C_070509.CEL.gz	2005-07-09	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
47	Patient 19	GSM1019143	1	18.5333333333333	adeno	StageI-II	< 65	Female	3	3	15.6666666666667	GSM1019143_PA025_19A_081028_HG-U133_Plus_2_.CEL.gz	2008-10-28	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
48	Patient 22	GSM1019144	1	10.1333333333333	adeno	StageIII-IV	>= 65	Male	1	3	3.03333333333333	GSM1019144_PA025_22B_081028_HG-U133_Plus_2_.CEL.gz	2008-10-28	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
49	Patient 23	GSM1019145	1	19.6666666666667	adeno	StageI-II	>= 65	Female	1	1	7.4	GSM1019145_PA025_23A_081029_HG-U133_Plus_2_.CEL.gz	2008-10-29	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
50	Patient 48	GSM1019152	1	17.4333333333333	adeno	StageI-II	< 65	Female	2	2	NA	GSM1019152_PA025_human_48A_070509.CEL.gz	2005-07-09	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
51	Patient 61	GSM1019153	1	13.1	adeno	StageIII-IV	>= 65	Male	2	2	NA	GSM1019153_PA025_61A_081029_HG-U133_Plus_2_.CEL.gz	2008-10-29	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
52	Patient 81	GSM1019154	1	8.33333333333333	adeno	StageIII-IV	< 65	Male	2	2	NA	GSM1019154_PA025_human_81A_070509.CEL.gz	2005-07-09	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
53	Patient 112	GSM1019158	1	16.3333333333333	adeno	StageI-II	>= 65	Male	3	3	14.5666666666667	GSM1019158_PA025_human_112B_070912.CEL.gz	2009-07-12	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
54	Patient 133	GSM1019160	1	2.8	adeno	StageI-II	>= 65	Female	1	1	2.76666666666667	GSM1019160_PA025_133A_081106_HG-U133_Plus_2_.CEL.gz	2008-11-06	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
55	Patient 165	GSM1019163	1	2.93333333333333	adeno	StageI-II	>= 65	Male	2	2	NA	GSM1019163_PA025_human_165C_070509.CEL.gz	2005-07-09	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
56	Patient 172	GSM1019166	1	70.2666666666667	adeno	StageI-II	>= 65	Female	1	3	37.3	GSM1019166_PA025_human_172C_070912.CEL.gz	2009-07-12	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
57	Patient 192	GSM1019170	1	134.333333333333	adeno	StageI-II	>= 65	Male	1	1	134.7	GSM1019170_PA025_192C_081106_HG-U133_Plus_2_.CEL.gz	2008-11-06	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
58	Patient 200	GSM1019175	0	190.4	adeno	StageI-II	< 65	Male	1	1	98.4666666666667	GSM1019175_PA025_200A_081029_HG-U133_Plus_2_.CEL.gz	2008-10-29	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
59	Patient 224	GSM1019186	0	128.133333333333	adeno	StageI-II	< 65	Female	3	1	69.5333333333333	GSM1019186_PA025_224A_081028_HG-U133_Plus_2_.CEL.gz	2008-10-28	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
60	Patient 229	GSM1019188	0	124.1	adeno	StageI-II	< 65	Female	3	1	32.2	GSM1019188_PA025_human_229A_070912.CEL.gz	2009-07-12	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
61	Patient 258	GSM1019196	1	0.2	adeno	StageIII-IV	< 65	Male	1	1	0.2	GSM1019196_PA025_human_258A_071005.CEL.gz	2010-07-05	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
62	Patient 260	GSM1019197	1	6.53333333333333	adeno	StageI-II	< 65	Male	1	3	4.43333333333333	GSM1019197_PA025_260A_081029_HG-U133_Plus_2_.CEL.gz	2008-10-29	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
63	Patient 272	GSM1019200	1	11.7	adeno	StageI-II	< 65	Female	2	2	NA	GSM1019200_PA025_272B_081029_HG-U133_Plus_2_.CEL.gz	2008-10-29	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
64	Patient 284	GSM1019204	1	131.633333333333	adeno	StageI-II	>= 65	Male	3	3	79.3333333333333	GSM1019204_PA025_human_284A_070912.CEL.gz	2009-07-12	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
65	Patient 292	GSM1019207	1	8.23333333333333	adeno	StageI-II	< 65	Female	2	2	NA	GSM1019207_PA025_292B_081029_HG-U133_Plus_2_.CEL.gz	2008-10-29	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
66	Patient 297	GSM1019210	1	91.6	adeno	StageI-II	>= 65	Male	1	1	91.6666666666667	GSM1019210_PA025_human_297A_070912.CEL.gz	2009-07-12	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
67	Patient 338	GSM1019224	1	62.4666666666667	adeno	StageI-II	< 65	Female	3	3	8.5	GSM1019224_PA025_human_338A_071005.CEL.gz	2010-07-05	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
68	Patient 373	GSM1019236	1	118.166666666667	adeno	StageI-II	< 65	Female	3	3	105.633333333333	GSM1019236_PA025_human_373B_070907.CEL.gz	2009-07-07	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
69	Patient 7	GSM1019239	1	40.7333333333333	adeno	StageI-II	< 65	Male	2	2	NA	GSM1019239_PA117_7A_101118_HG-U133_Plus_2_.CEL.gz	2010-11-18	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
70	Patient 20	GSM1019243	1	34.3666666666667	adeno	StageI-II	< 65	Male	2	2	NA	GSM1019243_PA117_20A_101118_HG-U133_Plus_2_.CEL.gz	2010-11-18	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
71	Patient 28	GSM1019244	1	41.4333333333333	adeno	StageI-II	< 65	Female	2	2	NA	GSM1019244_PA117_28A_101118_HG-U133_Plus_2_.CEL.gz	2010-11-18	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
72	Patient 56	GSM1019253	1	28.5666666666667	adeno	StageI-II	< 65	Male	2	2	NA	GSM1019253_PA117_56A_101208_HG-U133_Plus_2_.CEL.gz	2010-12-08	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
73	Patient 62	GSM1019256	1	27.8666666666667	adeno	StageI-II	>= 65	Female	2	2	NA	GSM1019256_PA117_62A_101123_HG-U133_Plus_2_.CEL.gz	2010-11-23	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
74	Patient 68	GSM1019259	0	86.3	adeno	StageIII-IV	< 65	Female	2	2	NA	GSM1019259_PA117_68A_101123_HG-U133_Plus_2_.CEL.gz	2010-11-23	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
75	Patient 75	GSM1019261	0	76.9333333333333	adeno	StageI-II	< 65	Male	2	2	NA	GSM1019261_PA117_75A_101126_HG-U133_Plus_2_2.CEL.gz	2010-11-26	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
76	Patient 79	GSM1019264	1	40.1666666666667	adeno	StageIII-IV	>= 65	Female	2	2	NA	GSM1019264_PA117_79A_101126_HG-U133_Plus_2_.CEL.gz	2010-11-26	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
77	Patient 93	GSM1019268	0	81.6	adeno	StageI-II	< 65	Male	2	2	NA	GSM1019268_PA117_93A_101126_HG-U133_Plus_2_.CEL.gz	2010-11-26	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
78	Patient 101	GSM1019270	1	33.3333333333333	adeno	StageIII-IV	>= 65	Male	2	2	NA	GSM1019270_PA117_101A_101203_HG-U133_Plus_2_.CEL.gz	2010-12-03	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
79	Patient 107	GSM1019272	1	40.8	adeno	StageI-II	>= 65	Female	2	2	NA	GSM1019272_PA117_107A_101215_HG-U133_Plus_2_.CEL.gz	2010-12-15	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
80	Patient 111	GSM1019274	1	1.66666666666667	adeno	StageI-II	< 65	Female	2	2	NA	GSM1019274_PA117_111A_101215_HG-U133_Plus_2_.CEL.gz	2010-12-15	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
81	Patient 164	GSM1019290	1	50	adeno	StageI-II	>= 65	Female	2	2	NA	GSM1019290_PA117_164A_101210_HG-U133_Plus_2_.CEL.gz	2010-12-10	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
82	Patient 173	GSM1019292	1	39.3666666666667	adeno	StageI-II	>= 65	Male	2	2	NA	GSM1019292_PA117_173B_101130_HG-U133_Plus_2_.CEL.gz	2010-11-30	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
83	Patient 187	GSM1019299	1	53.6666666666667	adeno	StageI-II	< 65	Male	2	2	NA	GSM1019299_PA117_187A_101130_HG-U133_Plus_2_.CEL.gz	2010-11-30	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
84	Patient 190	GSM1019300	1	45.5666666666667	adeno	StageI-II	>= 65	Male	2	2	NA	GSM1019300_PA117_190B_101202_HG-U133_Plus_2_.CEL.gz	2010-12-02	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
85	Patient 218	GSM1019303	1	25.5333333333333	adeno	StageI-II	< 65	Male	2	2	NA	GSM1019303_PA117_218A_101203_HG-U133_Plus_2_.CEL.gz	2010-12-03	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
86	Patient 226	GSM1019305	0	128.2	adeno	StageI-II	>= 65	Female	1	1	135.733333333333	GSM1019305_PA117_226B_101202_HG-U133_Plus_2_.CEL.gz	2010-12-02	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
87	Patient 254	GSM1019310	0	107.233333333333	adeno	StageIII-IV	< 65	Female	2	2	NA	GSM1019310_PA117_254A_101203_HG-U133_Plus_2_.CEL.gz	2010-12-03	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
88	Patient 275	GSM1019313	0	168.766666666667	adeno	StageI-II	< 65	Female	1	1	168.166666666667	GSM1019313_PA117_275A_101210_HG-U133_Plus_2_.CEL.gz	2010-12-10	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
89	Patient 285	GSM1019316	1	48.1666666666667	adeno	StageI-II	>= 65	Female	2	2	NA	GSM1019316_PA117_285A_101210_HG-U133_Plus_2_.CEL.gz	2010-12-10	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
90	Patient 290	GSM1019318	1	68.6666666666667	adeno	StageI-II	< 65	Female	2	2	NA	GSM1019318_PA117_290A_101210_HG-U133_Plus_2_.CEL.gz	2010-12-10	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
91	Patient 312	GSM1019320	1	49.6	adeno	StageI-II	< 65	Male	2	2	NA	GSM1019320_PA117_312A_101202_HG-U133_Plus_2_.CEL.gz	2010-12-02	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
92	Patient 353	GSM1019330	0	83.8333333333333	adeno	StageI-II	< 65	Male	2	2	NA	GSM1019330_PA117_353A_101208_HG-U133_Plus_2_.CEL.gz	2010-12-08	Cluster3	GSE37745	NA	NA	NA	NA	NA	NA	NA	NA	NA
93	MB003	GSM1213671	0	87.84	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213671_MB003_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster1	GSE50081	T2	N0	M0	Current	87.888	NA	NA	NA	NA
94	MB005	GSM1213673	1	22.92	adenocarcinoma	StageI-II	>= 65	Male	NA	1	NA	GSM1213673_MB005_HG-U133_Plus_2_.CEL.gz	2009-07-09	Cluster1	GSE50081	T2	N0	M0	Current	19.356	NA	NA	NA	NA
95	MB009	GSM1213677	0	74.64	adenocarcinoma	StageI-II	< 65	Female	NA	0	NA	GSM1213677_MB009_HG-U133_Plus_2_.CEL.gz	2009-07-09	Cluster1	GSE50081	T2	N0	M0	Never	74.616	NA	NA	NA	NA
96	MB011	GSM1213678	1	48.96	adenocarcinoma	StageI-II	>= 65	Female	NA	1	NA	GSM1213678_MB011_HG-U133_Plus_2_.CEL.gz	2009-07-09	Cluster1	GSE50081	T2	N1	M0	Never	44.916	NA	NA	NA	NA
97	MB014	GSM1213681	0	63.84	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213681_MB014_HG-U133_Plus_2_.CEL.gz	2009-07-15	Cluster1	GSE50081	T2	N0	M0	Ex-smoker	63.804	NA	NA	NA	NA
98	MB017	GSM1213683	0	60.24	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213683_MB017_HG-U133_Plus_2_.CEL.gz	2009-07-09	Cluster1	GSE50081	T2	N0	M0	Ex-smoker	60.216	NA	NA	NA	NA
99	MB019	GSM1213685	0	81.12	adenocarcinoma	StageI-II	< 65	Male	NA	0	NA	GSM1213685_MB019_HG-U133_Plus_2_.CEL.gz	2009-07-09	Cluster1	GSE50081	T1	N0	M0	Current	81.084	NA	NA	NA	NA
100	MB020	GSM1213686	1	34.08	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213686_MB020_HG-U133_Plus_2_.CEL.gz	2009-07-15	Cluster1	GSE50081	T2	N0	M0	Ex-smoker	34.032	NA	NA	NA	NA
101	MB021	GSM1213687	0	77.52	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213687_MB021_HG-U133_Plus_2_.CEL.gz	2009-07-09	Cluster1	GSE50081	T2	N0	M0	Current	77.472	NA	NA	NA	NA
102	MB022	GSM1213688	0	69.12	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213688_MB022_HG-U133_Plus_2_.CEL.gz	2009-07-15	Cluster1	GSE50081	T1	N0	M0	Ex-smoker	69.096	NA	NA	NA	NA
103	MB024	GSM1213690	0	61.44	adenocarcinoma	StageI-II	>= 65	Female	NA	1	NA	GSM1213690_MB024_HG-U133_Plus_2_.CEL.gz	2009-07-15	Cluster1	GSE50081	T2	N1	M0	Ex-smoker	58.584	NA	NA	NA	NA
104	MB029	GSM1213694	0	80.28	adenocarcinoma	StageI-II	>= 65	Female	NA	1	NA	GSM1213694_MB029_HG-U133_Plus_2_.CEL.gz	2009-07-09	Cluster1	GSE50081	T1	N1	M0	Never	37.224	NA	NA	NA	NA
105	MB031	GSM1213696	0	62.16	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213696_MB031_HG-U133_Plus_2_.CEL.gz	2009-07-09	Cluster1	GSE50081	T2	N0	M0	Ex-smoker	62.16	NA	NA	NA	NA
106	MB037	GSM1213702	1	35.16	adenocarcinoma	StageI-II	< 65	Male	NA	0	NA	GSM1213702_MB037_HG-U133_Plus_2_.CEL.gz	2009-07-17	Cluster1	GSE50081	T3	N0	M0	Current	35.124	NA	NA	NA	NA
107	MB039	GSM1213704	0	66.48	adenocarcinoma	StageI-II	< 65	Male	NA	1	NA	GSM1213704_MB039_HG-U133_Plus_2_.CEL.gz	2009-07-17	Cluster1	GSE50081	T2	N1	M0	Never	59.568	NA	NA	NA	NA
108	MB053	GSM1213715	0	88.32	adenocarcinoma	StageI-II	>= 65	Female	NA	1	NA	GSM1213715_MB053_HG-U133_Plus_2_.CEL.gz	2009-07-17	Cluster1	GSE50081	T2	N1	M0	Ex-smoker	48.264	NA	NA	NA	NA
109	MB054	GSM1213716	1	52.44	adenocarcinoma	StageI-II	>= 65	Male	NA	1	NA	GSM1213716_MB054_HG-U133_Plus_2_.CEL.gz	2009-07-29	Cluster1	GSE50081	T2	N0	M0	Ex-smoker	52.404	NA	NA	NA	NA
110	MB062	GSM1213720	0	76.44	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213720_MB062_HG-U133_Plus_2_.CEL.gz	2009-09-04	Cluster1	GSE50081	T1	N0	M0	Ex-smoker	76.452	NA	NA	NA	NA
111	MB072	GSM1213728	0	64.68	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213728_MB072_HG-U133_Plus_2_.CEL.gz	2009-07-24	Cluster1	GSE50081	T1	N0	M0	Ex-smoker	64.656	NA	NA	NA	NA
112	MB081	GSM1213735	0	72.72	adenocarcinoma	StageI-II	>= 65	Female	NA	1	NA	GSM1213735_MB081_HG-U133_Plus_2_.CEL.gz	2009-07-29	Cluster1	GSE50081	T2	N0	M0	Ex-smoker	14.784	NA	NA	NA	NA
113	MB084	GSM1213738	1	46.2	adenocarcinoma	StageI-II	< 65	Male	NA	0	NA	GSM1213738_MB084_HG-U133_Plus_2_.CEL.gz	2009-07-24	Cluster1	GSE50081	T1	N1	M0	Current	46.224	NA	NA	NA	NA
114	MB087	GSM1213741	1	76.2	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213741_MB087_HG-U133_Plus_2_.CEL.gz	2009-08-07	Cluster1	GSE50081	T2	N0	M0	Never	76.224	NA	NA	NA	NA
115	MB088	GSM1213742	1	63.12	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213742_MB088_HG-U133_Plus_2_.CEL.gz	2009-07-24	Cluster1	GSE50081	T2	N1	M0	Ex-smoker	63.108	NA	NA	NA	NA
116	MB093	GSM1213747	0	49.56	adenocarcinoma	StageI-II	< 65	Female	NA	0	NA	GSM1213747_MB093_HG-U133_Plus_2_.CEL.gz	2009-08-07	Cluster1	GSE50081	T1	N1	M0	Ex-smoker	49.548	NA	NA	NA	NA
117	MB095	GSM1213749	1	38.4	adenocarcinoma	StageI-II	>= 65	Male	NA	1	NA	GSM1213749_MB095_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster1	GSE50081	T2	N0	M0	Never	14.592	NA	NA	NA	NA
118	MB096	GSM1213750	1	12.36	adenocarcinoma	StageI-II	< 65	Male	NA	1	NA	GSM1213750_MB096_HG-U133_Plus_2_.CEL.gz	2009-08-07	Cluster1	GSE50081	T2	N1	M0	Current	11.076	NA	NA	NA	NA
119	MB098	GSM1213752	1	11.64	adenocarcinoma	StageI-II	< 65	Male	NA	1	NA	GSM1213752_MB098_HG-U133_Plus_2_.CEL.gz	2009-08-07	Cluster1	GSE50081	T2	N0	M0	Ex-smoker	9.852	NA	NA	NA	NA
120	MB100	GSM1213754	1	24.24	adenocarcinoma	StageI-II	>= 65	Male	NA	1	NA	GSM1213754_MB100_HG-U133_Plus_2_.CEL.gz	2009-08-07	Cluster1	GSE50081	T2	N1	M0	Current	8.412	NA	NA	NA	NA
121	MB102	GSM1213756	0	63.24	adenocarcinoma	StageI-II	< 65	Male	NA	0	NA	GSM1213756_MB102_HG-U133_Plus_2_.CEL.gz	2009-08-07	Cluster1	GSE50081	T1	N0	M0	Ex-smoker	63.276	NA	NA	NA	NA
122	MB105	GSM1213758	0	66.12	adenocarcinoma	StageI-II	< 65	Male	NA	1	NA	GSM1213758_MB105_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster1	GSE50081	T2	N0	M0	Ex-smoker	25.428	NA	NA	NA	NA
123	MB107	GSM1213760	0	54.84	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213760_MB107_HG-U133_Plus_2_.CEL.gz	2009-08-14	Cluster1	GSE50081	T1	N0	M0	Ex-smoker	54.9	NA	NA	NA	NA
124	MB108	GSM1213761	0	59.16	adenocarcinoma	StageI-II	< 65	Female	NA	0	NA	GSM1213761_MB108_HG-U133_Plus_2_.CEL.gz	2009-08-07	Cluster1	GSE50081	T1	N0	M0	Current	59.136	NA	NA	NA	NA
125	MB125	GSM1213777	0	65.4	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213777_MB125_HG-U133_Plus_2_.CEL.gz	2009-08-14	Cluster1	GSE50081	T2	N0	M0	Ex-smoker	65.352	NA	NA	NA	NA
126	MB130	GSM1213782	0	38.52	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213782_MB130_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster1	GSE50081	T1	N0	M0	Ex-smoker	38.568	NA	NA	NA	NA
127	MB132	GSM1213784	0	62.4	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213784_MB132_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster1	GSE50081	T1	N0	M0	Ex-smoker	62.46	NA	NA	NA	NA
128	MB140	GSM1213792	1	35.04	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213792_MB140_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster1	GSE50081	T2	N0	M0	Ex-smoker	34.992	NA	NA	NA	NA
129	MB145	GSM1213794	0	59.88	adenocarcinoma	StageI-II	< 65	Female	NA	0	NA	GSM1213794_MB145_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster1	GSE50081	T1	N0	M0	Never	59.856	NA	NA	NA	NA
130	MB146	GSM1213795	0	80.04	adenocarcinoma	StageI-II	< 65	Female	NA	0	NA	GSM1213795_MB146_HG-U133_Plus_2_.CEL.gz	2009-08-28	Cluster1	GSE50081	T1	N0	M0	Unabletodetermine	80.1	NA	NA	NA	NA
131	MB149	GSM1213798	0	130.56	adenocarcinoma	StageI-II	>= 65	Male	NA	NA	NA	GSM1213798_MB149_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster1	GSE50081	T2	N0	M0	Ex-smoker	0.228	NA	NA	NA	NA
132	MB151	GSM1213800	0	6.12	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213800_MB151_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster1	GSE50081	T1	N0	M0	Never	6.18	NA	NA	NA	NA
133	MB155	GSM1213804	0	93.96	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213804_MB155_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster1	GSE50081	T2	N0	M0	Unabletodetermine	93.996	NA	NA	NA	NA
134	MB161	GSM1213809	0	15.24	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213809_MB161_HG-U133_Plus_2_.CEL.gz	2009-08-28	Cluster1	GSE50081	T1	N0	M0	Ex-smoker	15.276	NA	NA	NA	NA
135	MB162	GSM1213810	0	1.8	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213810_MB162_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster1	GSE50081	T2	N0	M0	Never	1.836	NA	NA	NA	NA
136	MB171	GSM1213818	0	40.56	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213818_MB171_HG-U133_Plus_2_.CEL.gz	2009-08-28	Cluster1	GSE50081	T2	N1	M0	Ex-smoker	40.548	NA	NA	NA	NA
137	MB172	GSM1213819	1	18.24	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213819_MB172_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster1	GSE50081	T2	N0	M0	Unabletodetermine	18.264	NA	NA	NA	NA
138	MB173	GSM1213820	1	22.92	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213820_MB173_HG-U133_Plus_2_.CEL.gz	2009-09-04	Cluster1	GSE50081	T2	N0	M0	Unabletodetermine	22.872	NA	NA	NA	NA
139	MB177	GSM1213824	1	19.08	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213824_MB177_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster1	GSE50081	T2	N1	M0	Ex-smoker	19.092	NA	NA	NA	NA
140	MB199	GSM1213840	1	14.76	adenocarcinoma	StageI-II	>= 65	Female	NA	NA	NA	GSM1213840_MB199_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster1	GSE50081	T1	N0	M0	Unabletodetermine	0.192	NA	NA	NA	NA
141	MB002	GSM1213670	0	90.24	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213670_MB002_HG-U133_Plus_2_.CEL.gz	2009-07-15	Cluster2	GSE50081	T1	N0	M0	Current	90.252	NA	NA	NA	NA
142	MB004	GSM1213672	0	82.08	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213672_MB004_HG-U133_Plus_2_.CEL.gz	2009-07-09	Cluster2	GSE50081	T1	N0	M0	Ex-smoker	82.104	NA	NA	NA	NA
143	MB008	GSM1213676	1	51.96	adenocarcinoma	StageI-II	>= 65	Male	NA	1	NA	GSM1213676_MB008_HG-U133_Plus_2_.CEL.gz	2009-07-15	Cluster2	GSE50081	T2	N0	M0	Ex-smoker	49.872	NA	NA	NA	NA
144	MB012	GSM1213679	0	75.72	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213679_MB012_HG-U133_Plus_2_.CEL.gz	2009-07-15	Cluster2	GSE50081	T1	N0	M0	Ex-smoker	75.732	NA	NA	NA	NA
145	MB013	GSM1213680	0	71.88	adenocarcinoma	StageI-II	< 65	Female	NA	0	NA	GSM1213680_MB013_HG-U133_Plus_2_.CEL.gz	2009-07-09	Cluster2	GSE50081	T2	N0	M0	Ex-smoker	71.856	NA	NA	NA	NA
146	MB016	GSM1213682	0	66.72	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213682_MB016_HG-U133_Plus_2_.CEL.gz	2009-07-15	Cluster2	GSE50081	T1	N0	M0	Ex-smoker	66.732	NA	NA	NA	NA
147	MB023	GSM1213689	0	59.4	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213689_MB023_HG-U133_Plus_2_.CEL.gz	2009-07-09	Cluster2	GSE50081	T1	N0	M0	Never	59.4	NA	NA	NA	NA
148	MB025	GSM1213691	0	76.68	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213691_MB025_HG-U133_Plus_2_.CEL.gz	2009-07-09	Cluster2	GSE50081	T2	N0	M0	Current	76.716	NA	NA	NA	NA
149	MB026	GSM1213692	1	68.88	adenocarcinoma	StageI-II	< 65	Female	NA	0	NA	GSM1213692_MB026_HG-U133_Plus_2_.CEL.gz	2009-07-15	Cluster2	GSE50081	T1	N0	M0	Never	68.928	NA	NA	NA	NA
150	MB030	GSM1213695	0	70.08	adenocarcinoma	StageI-II	< 65	Female	NA	0	NA	GSM1213695_MB030_HG-U133_Plus_2_.CEL.gz	2009-07-15	Cluster2	GSE50081	T2	N1	M0	Current	70.116	NA	NA	NA	NA
151	MB032	GSM1213697	0	76.44	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213697_MB032_HG-U133_Plus_2_.CEL.gz	2009-07-15	Cluster2	GSE50081	T2	N0	M0	Current	76.416	NA	NA	NA	NA
152	MB033	GSM1213698	1	67.56	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213698_MB033_HG-U133_Plus_2_.CEL.gz	2009-07-17	Cluster2	GSE50081	T2	N1	M0	Current	67.608	NA	NA	NA	NA
153	MB034	GSM1213699	1	22.56	adenocarcinoma	StageI-II	< 65	Male	NA	1	NA	GSM1213699_MB034_HG-U133_Plus_2_.CEL.gz	2009-07-15	Cluster2	GSE50081	T1	N0	M0	Never	15.9	NA	NA	NA	NA
154	MB035	GSM1213700	1	48.36	adenocarcinoma	StageI-II	>= 65	Female	NA	1	NA	GSM1213700_MB035_HG-U133_Plus_2_.CEL.gz	2009-07-17	Cluster2	GSE50081	T2	N0	M0	Never	22.44	NA	NA	NA	NA
155	MB038	GSM1213703	1	71.52	adenocarcinoma	StageI-II	>= 65	Female	NA	1	NA	GSM1213703_MB038_HG-U133_Plus_2_.CEL.gz	2009-07-29	Cluster2	GSE50081	T2	N0	M0	Never	69.024	NA	NA	NA	NA
156	MB042	GSM1213707	0	64.92	adenocarcinoma	StageI-II	< 65	Female	NA	1	NA	GSM1213707_MB042_HG-U133_Plus_2_.CEL.gz	2009-07-29	Cluster2	GSE50081	T2	N0	M0	Never	20.7	NA	NA	NA	NA
157	MB047	GSM1213710	0	3.96	adenocarcinoma	StageI-II	>= 65	Male	NA	1	NA	GSM1213710_MB047_HG-U133_Plus_2_.CEL.gz	2009-07-17	Cluster2	GSE50081	T2	N1	M0	Current	2.568	NA	NA	NA	NA
158	MB055	GSM1213717	1	58.92	adenocarcinoma	StageI-II	< 65	Male	NA	1	NA	GSM1213717_MB055_HG-U133_Plus_2_.CEL.gz	2009-07-17	Cluster2	GSE50081	T2	N0	M0	Ex-smoker	43.296	NA	NA	NA	NA
159	MB064	GSM1213722	1	15	adenocarcinoma	StageI-II	>= 65	Female	NA	1	NA	GSM1213722_MB064_HG-U133_Plus_2_.CEL.gz	2009-07-29	Cluster2	GSE50081	T2	N0	M0	Current	6.996	NA	NA	NA	NA
160	MB070	GSM1213726	0	78.72	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213726_MB070_HG-U133_Plus_2_.CEL.gz	2009-07-24	Cluster2	GSE50081	T2	N1	M0	Ex-smoker	78.756	NA	NA	NA	NA
161	MB071	GSM1213727	1	69.48	adenocarcinoma	StageI-II	< 65	Male	NA	1	NA	GSM1213727_MB071_HG-U133_Plus_2_.CEL.gz	2009-07-29	Cluster2	GSE50081	T1	N1	M0	Current	21.492	NA	NA	NA	NA
162	MB074	GSM1213730	1	38.52	adenocarcinoma	StageI-II	>= 65	Male	NA	1	NA	GSM1213730_MB074_HG-U133_Plus_2_.CEL.gz	2009-07-24	Cluster2	GSE50081	T2	N0	M0	Ex-smoker	9.588	NA	NA	NA	NA
163	MB079	GSM1213734	0	61.92	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213734_MB079_HG-U133_Plus_2_.CEL.gz	2009-07-29	Cluster2	GSE50081	T2	N1	M0	Ex-smoker	61.932	NA	NA	NA	NA
164	MB082	GSM1213736	1	10.92	adenocarcinoma	StageI-II	< 65	Female	NA	1	NA	GSM1213736_MB082_HG-U133_Plus_2_.CEL.gz	2009-07-24	Cluster2	GSE50081	T2	N0	M0	Ex-smoker	10.644	NA	NA	NA	NA
165	MB086	GSM1213740	0	70.08	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213740_MB086_HG-U133_Plus_2_.CEL.gz	2009-07-24	Cluster2	GSE50081	T2	N0	M0	Never	70.116	NA	NA	NA	NA
166	MB092	GSM1213746	0	62.04	adenocarcinoma	StageI-II	< 65	Male	NA	0	NA	GSM1213746_MB092_HG-U133_Plus_2_.CEL.gz	2009-07-24	Cluster2	GSE50081	T2	N0	M0	Current	62.1	NA	NA	NA	NA
167	MB097	GSM1213751	0	58.92	adenocarcinoma	StageI-II	< 65	Female	NA	0	NA	GSM1213751_MB097_HG-U133_Plus_2_.CEL.gz	2009-08-14	Cluster2	GSE50081	T1	N0	M0	Ex-smoker	58.944	NA	NA	NA	NA
168	MB104	GSM1213757	0	69	adenocarcinoma	StageI-II	>= 65	Male	NA	1	NA	GSM1213757_MB104_HG-U133_Plus_2_.CEL.gz	2009-08-07	Cluster2	GSE50081	T2	N0	M0	Ex-smoker	3.288	NA	NA	NA	NA
169	MB109	GSM1213762	1	10.32	adenocarcinoma	StageI-II	< 65	Female	NA	1	NA	GSM1213762_MB109_HG-U133_Plus_2_.CEL.gz	2009-08-14	Cluster2	GSE50081	T3	N0	M0	Current	1.344	NA	NA	NA	NA
170	MB110	GSM1213763	1	23.4	adenocarcinoma	StageI-II	< 65	Female	NA	0	NA	GSM1213763_MB110_HG-U133_Plus_2_.CEL.gz	2009-08-07	Cluster2	GSE50081	T2	N0	M0	Current	23.46	NA	NA	NA	NA
171	MB111	GSM1213764	0	93	adenocarcinoma	StageI-II	< 65	Female	NA	0	NA	GSM1213764_MB111_HG-U133_Plus_2_.CEL.gz	2009-08-14	Cluster2	GSE50081	T2	N0	M0	Never	92.94	NA	NA	NA	NA
172	MB116	GSM1213769	0	63.48	adenocarcinoma	StageI-II	< 65	Female	NA	1	NA	GSM1213769_MB116_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster2	GSE50081	T1	N0	M0	Ex-smoker	44.652	NA	NA	NA	NA
173	MB120	GSM1213773	1	57.48	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213773_MB120_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster2	GSE50081	T2	N0	M0	Ex-smoker	57.528	NA	NA	NA	NA
174	MB122	GSM1213774	1	36.12	adenocarcinoma	StageI-II	>= 65	Male	NA	1	NA	GSM1213774_MB122_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster2	GSE50081	T2	N1	M0	Current	34.656	NA	NA	NA	NA
175	MB123	GSM1213775	1	37.68	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213775_MB123_HG-U133_Plus_2_.CEL.gz	2009-08-14	Cluster2	GSE50081	T1	N0	M0	Current	37.716	NA	NA	NA	NA
176	MB127	GSM1213779	0	37.32	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213779_MB127_HG-U133_Plus_2_.CEL.gz	2009-08-14	Cluster2	GSE50081	T2	N0	M0	Current	37.284	NA	NA	NA	NA
177	MB128	GSM1213780	1	7.8	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213780_MB128_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster2	GSE50081	T1	N0	M0	Unabletodetermine	7.848	NA	NA	NA	NA
178	MB131	GSM1213783	1	7.2	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213783_MB131_HG-U133_Plus_2_.CEL.gz	2009-08-14	Cluster2	GSE50081	T1	N0	M0	Ex-smoker	7.2	NA	NA	NA	NA
179	MB135	GSM1213787	0	41.16	adenocarcinoma	StageI-II	>= 65	Female	NA	1	NA	GSM1213787_MB135_HG-U133_Plus_2_.CEL.gz	2009-08-28	Cluster2	GSE50081	T2	N0	M0	Never	34.956	NA	NA	NA	NA
180	MB136	GSM1213788	1	17.88	adenocarcinoma	StageI-II	>= 65	Male	NA	1	NA	GSM1213788_MB136_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster2	GSE50081	T2	N1	M0	Ex-smoker	14.292	NA	NA	NA	NA
181	MB141	GSM1213793	0	32.28	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213793_MB141_HG-U133_Plus_2_.CEL.gz	2009-08-28	Cluster2	GSE50081	T2	N0	M0	Never	32.232	NA	NA	NA	NA
182	MB152	GSM1213801	1	48.48	adenocarcinoma	StageI-II	>= 65	Male	NA	NA	NA	GSM1213801_MB152_HG-U133_Plus_2_.CEL.gz	2009-08-28	Cluster2	GSE50081	T1	N1	M0	Ex-smoker	0.324	NA	NA	NA	NA
183	MB154	GSM1213803	0	18.48	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213803_MB154_HG-U133_Plus_2_.CEL.gz	2009-08-28	Cluster2	GSE50081	T2	N0	M0	Current	18.432	NA	NA	NA	NA
184	MB156	GSM1213805	0	72.24	adenocarcinoma	StageI-II	< 65	Male	NA	0	NA	GSM1213805_MB156_HG-U133_Plus_2_.CEL.gz	2009-08-28	Cluster2	GSE50081	T2	N0	M0	Ex-smoker	72.252	NA	NA	NA	NA
185	MB157	GSM1213806	0	20.52	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213806_MB157_HG-U133_Plus_2_.CEL.gz	2009-08-26	Cluster2	GSE50081	T2	N0	M0	Current	20.568	NA	NA	NA	NA
186	MB158	GSM1213807	0	8.52	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213807_MB158_HG-U133_Plus_2_.CEL.gz	2009-08-28	Cluster2	GSE50081	T2	N1	M0	Current	8.472	NA	NA	NA	NA
187	MB163	GSM1213811	0	16.44	adenocarcinoma	StageI-II	< 65	Male	NA	0	NA	GSM1213811_MB163_HG-U133_Plus_2_.CEL.gz	2009-08-28	Cluster2	GSE50081	T1	N1	M0	Ex-smoker	16.464	NA	NA	NA	NA
188	MB164	GSM1213812	1	9.6	adenocarcinoma	StageI-II	< 65	Male	NA	0	NA	GSM1213812_MB164_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster2	GSE50081	T2	N1	M0	Ex-smoker	9.624	NA	NA	NA	NA
189	MB167	GSM1213814	0	61.2	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213814_MB167_HG-U133_Plus_2_.CEL.gz	2009-08-28	Cluster2	GSE50081	T2	N0	M0	Ex-smoker	61.236	NA	NA	NA	NA
190	MB169	GSM1213816	0	1.08	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213816_MB169_HG-U133_Plus_2_.CEL.gz	2009-08-28	Cluster2	GSE50081	T2	N1	M0	Unabletodetermine	1.116	NA	NA	NA	NA
191	MB191	GSM1213833	1	6.72	adenocarcinoma	StageI-II	>= 65	Female	NA	1	NA	GSM1213833_MB191_HG-U133_Plus_2_.CEL.gz	2009-09-04	Cluster2	GSE50081	T2	N0	M0	Ex-smoker	1.512	NA	NA	NA	NA
192	MB192	GSM1213834	0	32.52	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213834_MB192_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster2	GSE50081	T2	N0	M0	Unabletodetermine	32.496	NA	NA	NA	NA
193	MB195	GSM1213837	1	91.32	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213837_MB195_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster2	GSE50081	T2	N0	M0	Current	91.296	NA	NA	NA	NA
194	MB203	GSM1213844	0	54.48	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213844_MB203_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster2	GSE50081	T1	N0	M0	Unabletodetermine	54.468	NA	NA	NA	NA
195	MB205	GSM1213846	1	3.72	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213846_MB205_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster2	GSE50081	T2	N0	M0	Current	3.78	NA	NA	NA	NA
196	MB206	GSM1213847	0	99.12	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213847_MB206_HG-U133_Plus_2_.CEL.gz	2009-09-04	Cluster2	GSE50081	T1	N0	M0	Never	99.156	NA	NA	NA	NA
197	MB207	GSM1213848	1	1.2	adenocarcinoma	StageI-II	>= 65	Female	NA	0	NA	GSM1213848_MB207_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster2	GSE50081	T2	N1	M0	Ex-smoker	1.188	NA	NA	NA	NA
198	MB208	GSM1213849	0	49.92	adenocarcinoma	StageI-II	< 65	Female	NA	0	NA	GSM1213849_MB208_HG-U133_Plus_2_.CEL.gz	2009-09-04	Cluster2	GSE50081	T1	N0	M0	Current	49.944	NA	NA	NA	NA
199	MB066	GSM1213724	0	75.36	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213724_MB066_HG-U133_Plus_2_.CEL.gz	2009-07-29	Cluster3	GSE50081	T1	N0	M0	Ex-smoker	75.396	NA	NA	NA	NA
200	MB078	GSM1213733	1	41.76	adenocarcinoma	StageI-II	>= 65	Male	NA	1	NA	GSM1213733_MB078_HG-U133_Plus_2_.CEL.gz	2009-07-24	Cluster3	GSE50081	T2	N0	M0	Current	32.496	NA	NA	NA	NA
201	MB099	GSM1213753	1	37.08	adenocarcinoma	StageI-II	>= 65	Female	NA	1	NA	GSM1213753_MB099_HG-U133_Plus_2_.CEL.gz	2009-08-14	Cluster3	GSE50081	T2	N0	M0	Current	32.784	NA	NA	NA	NA
202	MB106	GSM1213759	0	65.88	adenocarcinoma	StageI-II	< 65	Male	NA	0	NA	GSM1213759_MB106_HG-U133_Plus_2_.CEL.gz	2009-08-07	Cluster3	GSE50081	T2	N0	M0	Current	65.94	NA	NA	NA	NA
203	MB181	GSM1213827	0	50.04	adenocarcinoma	StageI-II	< 65	Male	NA	0	NA	GSM1213827_MB181_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster3	GSE50081	T1	N0	M0	Current	50.04	NA	NA	NA	NA
204	MB187	GSM1213831	0	61.56	adenocarcinoma	StageI-II	>= 65	Male	NA	0	NA	GSM1213831_MB187_HG-U133_Plus_2_.CEL.gz	2009-09-02	Cluster3	GSE50081	T2	N1	M0	Unabletodetermine	61.5	NA	NA	NA	NA
205	CL2004111034AA	GSM370931	1	73.08	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM370931.CEL.gz	2011-04-10	Cluster1	GSE14814	NA	NA	NA	NA	NA	ACT	Otherconditions	6.09	0
206	CL2004111047AA	GSM370934	0	83.16	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM370934.CEL.gz	2011-04-10	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	6.93	0
207	CL2004111011AA	GSM370939	1	10.8	ADC	StageI-II	>= 65	Female	NA	NA	NA	GSM370939.CEL.gz	2011-04-10	Cluster1	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	0.9	1
208	CL2004111028AA	GSM370941	1	44.88	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM370941.CEL.gz	2011-04-10	Cluster1	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	3.74	1
209	CL20041116150AA	GSM370962	1	27.36	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM370962.CEL.gz	2011-04-16	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	2.28	1
210	CL20041116157AA	GSM370976	1	22.32	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM370976.CEL.gz	2011-04-16	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	1.86	1
211	CL20041116159AA	GSM370979	1	33.84	ADC	StageI-II	>= 65	Male	NA	NA	NA	GSM370979.CEL.gz	2011-04-16	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	2.82	1
212	CL20041119164AA	GSM370986	0	47.4	ADC	StageI-II	>= 65	Female	NA	NA	NA	GSM370986.CEL.gz	2011-04-19	Cluster1	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	3.95	0
213	CL20041119168AA	GSM370992	0	58.68	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM370992.CEL.gz	2011-04-19	Cluster1	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	4.89	0
214	CL2005060331AA	GSM370999	0	80.88	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM370999.CEL.gz	2006-05-03	Cluster1	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	6.74	0
215	CL2005060325AA	GSM371001	1	24.48	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM371001.CEL.gz	2006-05-03	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	2.04	1
216	B023	GSM1267450	0	96.72	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267450_CL2004110909AA.CEL.gz	2011-04-09	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	8.06	0
217	B008	GSM1267451	0	96.24	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267451_CL2004111002AA.CEL.gz	2011-04-10	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	8.02	0
218	B028	GSM1267454	0	105.72	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267454_CL2004111013AA.CEL.gz	2011-04-10	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	8.81	0
219	B035	GSM1267456	0	104.52	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267456_CL2004111018AA.CEL.gz	2011-04-10	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	8.71	0
220	B068	GSM1267458	1	93.84	ADC	StageI-II	>= 65	Female	NA	NA	NA	GSM1267458_CL2004111033AA.CEL.gz	2011-04-10	Cluster1	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	7.82	1
221	B088	GSM1267460	1	37.2	ADC	StageI-II	>= 65	Male	NA	NA	NA	GSM1267460_CL2004111040AA.CEL.gz	2011-04-10	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	3.1	1
222	B099	GSM1267463	1	36.36	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267463_CL2004111043AA.CEL.gz	2011-04-10	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	3.03	1
223	B111	GSM1267465	1	12	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267465_CL2004111045AA.CEL.gz	2011-04-10	Cluster1	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	1	1
224	B120	GSM1267469	0	73.44	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267469_CL20041116127AA.CEL.gz	2011-04-16	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	6.12	0
225	B057	GSM1267474	1	73.2	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267474_CL20041119175AA.CEL.gz	2011-04-19	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	6.1	1
226	B136	GSM1267476	1	6.96	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267476_CL2005060327AA.CEL.gz	2006-05-03	Cluster1	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	0.58	1
227	B140	GSM1267477	0	75.96	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267477_CL2005060328AA.CEL.gz	2006-05-03	Cluster1	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	6.33	0
228	B158	GSM1267479	1	3.24	ADC	StageI-II	>= 65	Male	NA	NA	NA	GSM1267479_CL2005060332AA.CEL.gz	2006-05-03	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	0.27	1
229	B188	GSM1267482	1	63.96	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267482_CL2005060336AA.CEL.gz	2006-05-03	Cluster1	GSE14814	NA	NA	NA	NA	NA	ACT	Otherconditions	5.33	0
230	B094	GSM1267484	1	7.8	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267484_CL2005060338AA.CEL.gz	2006-05-03	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	0.65	1
231	B299	GSM1267490	0	48.36	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267490_CL2005060344AA.CEL.gz	2006-05-03	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	4.03	0
232	B334	GSM1267491	0	38.88	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267491_CL2005060345AA.CEL.gz	2006-05-03	Cluster1	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	3.24	0
233	CL2004111016AA	GSM370917	0	98.76	ADC	StageI-II	>= 65	Female	NA	NA	NA	GSM370917.CEL.gz	2011-04-10	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	8.23	0
234	CL2004111021AA	GSM370920	1	0.36	ADC	StageI-II	>= 65	Female	NA	NA	NA	GSM370920.CEL.gz	2011-04-10	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Otherconditions	0.03	0
235	CL2004111024AA	GSM370928	1	19.08	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM370928.CEL.gz	2011-04-10	Cluster2	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	1.59	1
236	CL2004111039AA	GSM370933	1	2.28	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM370933.CEL.gz	2011-04-10	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Otherconditions	0.19	0
237	CL2004111029AA	GSM370935	0	92.52	ADC	StageI-II	>= 65	Male	NA	NA	NA	GSM370935.CEL.gz	2011-04-10	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	7.71	0
238	CL20041116119AA	GSM370944	0	86.4	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM370944.CEL.gz	2011-04-16	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	7.2	0
239	CL20041116148AA	GSM370951	0	70.44	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM370951.CEL.gz	2011-04-16	Cluster2	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	5.87	0
240	CL20041116153AA	GSM370956	0	65.04	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM370956.CEL.gz	2011-04-16	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	5.42	0
241	CL20041116149AA	GSM370958	0	60.36	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM370958.CEL.gz	2011-04-16	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	5.03	0
242	CL20041119161AA	GSM370985	0	53.52	ADC	StageI-II	>= 65	Male	NA	NA	NA	GSM370985.CEL.gz	2011-04-19	Cluster2	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	4.46	0
243	CL20041119166AA	GSM370987	0	42.12	ADC	StageI-II	>= 65	Female	NA	NA	NA	GSM370987.CEL.gz	2011-04-19	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	3.51	0
244	CL2005060335AA	GSM371000	0	64.56	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM371000.CEL.gz	2006-05-03	Cluster2	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	5.38	0
245	CL2005060330AA	GSM371002	1	72.36	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM371002.CEL.gz	2006-05-03	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Otherconditions	6.03	0
246	B009	GSM1267452	0	109.08	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267452_CL2004111003AA.CEL.gz	2011-04-10	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	9.09	0
247	B024	GSM1267453	1	77.88	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267453_CL2004111010AA.CEL.gz	2011-04-10	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	6.49	1
248	B034	GSM1267455	1	4.68	ADC	StageI-II	>= 65	Female	NA	NA	NA	GSM1267455_CL2004111017AA.CEL.gz	2011-04-10	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	0.39	1
249	B090	GSM1267461	1	14.16	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267461_CL2004111041AA.CEL.gz	2011-04-10	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	1.18	1
250	B092	GSM1267462	0	89.16	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267462_CL2004111042AA.CEL.gz	2011-04-10	Cluster2	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	7.43	0
251	B115	GSM1267466	1	69.96	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267466_CL2004111046AA.CEL.gz	2011-04-10	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	5.83	1
252	B126	GSM1267467	0	72.72	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267467_CL2004111048AA.CEL.gz	2011-04-10	Cluster2	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	6.06	0
253	B119	GSM1267468	0	83.04	ADC	StageI-II	>= 65	Female	NA	NA	NA	GSM1267468_CL20041116126AA.CEL.gz	2011-04-16	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	6.92	0
254	B139	GSM1267471	1	8.4	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267471_CL20041116136AA.CEL.gz	2011-04-16	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	0.7	1
255	B134	GSM1267475	0	81.84	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267475_CL2005060326AA.CEL.gz	2006-05-03	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	6.82	0
256	B107	GSM1267485	0	82.8	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267485_CL2005060339AA.CEL.gz	2006-05-03	Cluster2	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	6.9	0
257	B252	GSM1267487	1	9.24	ADC	StageI-II	>= 65	Male	NA	NA	NA	GSM1267487_CL2005060341AA.CEL.gz	2006-05-03	Cluster2	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	0.77	1
258	B350	GSM1267492	0	34.32	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267492_CL2005060346AA.CEL.gz	2006-05-03	Cluster2	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	2.86	0
259	CL2004110925AA	GSM370913	0	102.24	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM370913.CEL.gz	2011-04-09	Cluster3	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	8.52	0
260	CL2004111007AA	GSM370921	0	103.2	ADC	StageI-II	>= 65	Male	NA	NA	NA	GSM370921.CEL.gz	2011-04-10	Cluster3	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	8.6	0
261	B047	GSM1267457	1	23.16	ADC	StageI-II	>= 65	Male	NA	NA	NA	GSM1267457_CL2004111022AA.CEL.gz	2011-04-10	Cluster3	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	1.93	1
262	B086	GSM1267459	1	11.64	ADC	StageI-II	>= 65	Male	NA	NA	NA	GSM1267459_CL2004111038AA.CEL.gz	2011-04-10	Cluster3	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	0.97	1
263	B103	GSM1267464	0	85.92	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267464_CL2004111044AA.CEL.gz	2011-04-10	Cluster3	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	7.16	0
264	B114	GSM1267470	1	7.32	ADC	StageI-II	>= 65	Male	NA	NA	NA	GSM1267470_CL20041116134AA.CEL.gz	2011-04-16	Cluster3	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	0.61	1
265	B257	GSM1267472	0	56.52	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267472_CL20041116156AA.CEL.gz	2011-04-16	Cluster3	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	4.71	0
266	B384	GSM1267473	0	57.48	ADC	StageI-II	>= 65	Female	NA	NA	NA	GSM1267473_CL20041119167AA.CEL.gz	2011-04-19	Cluster3	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	4.79	0
267	B160	GSM1267480	1	69.72	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267480_CL2005060333AA.CEL.gz	2006-05-03	Cluster3	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	5.81	1
268	B176	GSM1267481	1	34.44	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267481_CL2005060334AA.CEL.gz	2006-05-03	Cluster3	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	2.87	1
269	B192	GSM1267483	1	63.24	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267483_CL2005060337AA.CEL.gz	2006-05-03	Cluster3	GSE14814	NA	NA	NA	NA	NA	ACT	Lungcancer	5.27	1
270	B250	GSM1267486	0	61.32	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267486_CL2005060340AA.CEL.gz	2006-05-03	Cluster3	GSE14814	NA	NA	NA	NA	NA	ACT	Alive	5.11	0
271	B259	GSM1267488	0	61.68	ADC	StageI-II	< 65	Female	NA	NA	NA	GSM1267488_CL2005060342AA.CEL.gz	2006-05-03	Cluster3	GSE14814	NA	NA	NA	NA	NA	OBS	Alive	5.14	0
272	B298	GSM1267489	1	43.2	ADC	StageI-II	< 65	Male	NA	NA	NA	GSM1267489_CL2005060343AA.CEL.gz	2006-05-03	Cluster3	GSE14814	NA	NA	NA	NA	NA	OBS	Lungcancer	3.6	1
